KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Inventory (2016 - 2025)

Gilead Sciences' Inventory history spans 17 years, with the latest figure at $1.8 billion for Q4 2025.

  • For Q4 2025, Inventory rose 3.74% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $1.8 billion, up 3.74%, while the annual FY2025 figure was $1.8 billion, 3.74% up from the prior year.
  • Inventory reached $1.8 billion in Q4 2025 per GILD's latest filing, down from $1.8 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $2.0 billion in Q2 2024 to a low of $1.5 billion in Q3 2022.
  • Average Inventory over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2024.
  • Peak YoY movement for Inventory: skyrocketed 80.43% in 2021, then decreased 16.69% in 2022.
  • A 5-year view of Inventory shows it stood at $1.6 billion in 2021, then dropped by 6.86% to $1.5 billion in 2022, then increased by 18.58% to $1.8 billion in 2023, then fell by 4.31% to $1.7 billion in 2024, then increased by 3.74% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Inventory are $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.8 billion (Q2 2025).